Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways Meeting Abstract
| Authors: | Venneti, S.; Kawakibi, A. R.; Ji, S.; Waszak, S.; Sweha, S.; Mota, M.; Pun, M.; Deogharkar, A.; Chung, C.; Tarapore, R.; Ramage, S.; Wen, P.; Arrillaga-Romany, I.; Garton, H.; Franson, A.; Schwartz, J.; Jain, R.; Mottl, S.; Cartaxo, R.; John, V.; Messinger, D.; Qin, T. T.; Peterson, E.; Sajjakulnukit, P.; Judkins, A.; Wahl, D.; Lyssiotis, C.; de la Nava, D.; Alonso, M.; Duchatel, R.; Dun, M.; Cain, J.; Jiang, L.; Filbin, M.; Zhao, L. L.; Kumar-Sinha, C.; Mody, R.; Chinnaiyan, A.; Kurokawa, R.; Pratt, D.; Yadav, V.; Grill, J.; Kline, C.; Mueller, S.; Resnick, A.; Nazarian, J.; Allen, J.; Odia, Y.; Gardner, S.; Koschmann, C. |
| Abstract Title: | Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v272 |
| Language: | English |
| ACCESSION: | WOS:001115245401257 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.1046 |
| Notes: | Meeting Abstract: TMET-02 -- Source: Wos |
